Filing Details
- Accession Number:
- 0001140361-14-024690
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-05 20:33:33
- Reporting Period:
- 2014-06-03
- Filing Date:
- 2014-06-05
- Accepted Time:
- 2014-06-05 19:33:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-06-03 | 1,000 | $59.88 | 179,257 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-04 | 1,000 | $62.52 | 178,257 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-04 | 50,900 | $0.00 | 229,157 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) Common Stock | Acquisiton | 2014-06-04 | 191,000 | $0.00 | 191,000 | $63.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 191,000 | 2014-12-04 | 2024-06-03 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 46,195 | Indirect | Shares held by Bienaime Family Trust |
Footnotes
- The reporting person and his spouse act as trustees for the Bienaime Family Trust.
- The price in column 4 is a weighted average price. The price actually received ranged from $59.86 to $59.878. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in column 4 is a weighted average price. The price actually received ranged from $61.55 to $62.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Restricted stock units granted on June 4, 2014. Price not applicable.
- Option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th day of every month thereafter.
Billionaire Hedge Funds
